Bibliography
- Spaete RR, Frenkel N. The herpes simplex virus amplicon: a new eucaryotic defective virus cloning-amplifying vector. Cell 1982;30(1):295-304
- Deiss LP, Chou J, Frenkel N. Functional domains within the a sequence involved in the cleavage-packaging of herpes simplex virus DNA. J Virol 1986;59(3):605-18
- Spaete RR, Frenkel N. The herpes simplex virus amplicon: analyses of cis-acting replication functions. Proc Natl Acad Sci USA 1985;82(3):694-8
- Vlazny DA, Frenkel N. Replication of herpes simplex virus DNA: localization of replication recognition signals within defective virus genomes. Proc Natl Acad Sci USA 1981;78(2):742-6
- Wade-Martins R, Smith ER, Tyminsky E, et al. An infectious transfer and expression system for genomic DNA loci in human and mouse cells. Nat Biotechnol 2001;19(11):1067-70
- Wade-Martins R, Saeki Y, Chiocca EA. Infectious delivery of a 135-kb LDLR genomic locus leads to regulated complementation of low-density lipoprotein receptor deficiency in human cells. Mol Ther 2003;7(5,1):604-12
- Hibbitt OC, Wade-Martins R. Delivery of large genomic DNA inserts >100 kb using HSV-1 amplicons. Curr Gene Ther 2006;6(3):325-36
- Cunningham C, Davison AJ. A cosmid-based system for constructing mutants of herpes simplex virus type 1. Virology 1993;197(1):116-24
- Stavropoulos TA, Strathdee CA. An enhanced packaging system for helper-dependent herpes simplex virus vectors. J Virol 1998;72(9):7137-43
- Fraeffel C, Song S, Lim F, et al. Helper virus-free transfer of herpes simplex virus type 1 plasmid vectors into neural cells. J Virol 1996;70(10):7190-7
- Horsburgh BC, Hubinette MM, Qiang D, et al. Allele replacement: an application that permits rapid manipulation of herpes simplex virus type 1 genomes. Gene Ther 1999;6(5):922-30
- Saeki Y, Ichikawa T, Saeki A, et al. Herpes simplex virus type 1 DNA amplified as bacterial artificial chromosome in Escherichia coli: rescue of replication-competent virus progeny and packaging of amplicon vectors. Hum Gene Ther 1998;9(18):2787-94
- Saeki Y, Breakefield XO, Chiocca EA. Improved HSV-1 amplicon packaging system using ICP27-deleted, oversized HSV-1 BAC DNA. Methods Mol Med 2003;76:51-60
- Saeki Y, Fraefel C, Ichikawa T, et al. Improved helper virus-free packaging system for HSV amplicon vectors using an ICP27-deleted, oversized HSV-1 DNA in a bacterial artificial chromosome. Mol Ther 2001;3(4):591-601
- Logvinoff C, Epstein AL. Genetic engineering of herpes simplex virus and vector genomes carrying loxP sites in cells expressing Cre recombinase. Virology 2000;267(1):102-10
- Zaupa C, Revol-Guyot V, Epstein AL. Improved packaging system for generation of high-level noncytotoxic HSV-1 amplicon vectors using Cre-loxP site-specific recombination to delete the packaging signals of defective helper genomes. Hum Gene Ther 2003;14(11):1049-63
- Cuchet D, Potel C, Thomas J, Epstein AL. HSV-1 amplicon vectors: a promising and versatile tool for gene delivery. Expert Opin Biol Ther 2007;7:975-95
- Tsai DJ, Ho JJ, Ozawa CR, Sapolsky RM. Long-term expression driven by herpes simplex virus type-1 amplicons may fail due to eventual degradation or extrusion of introduced transgenes. Exp Neurol 2000;165(1):58-65
- Suzuki M, Kasai K, Saeki Y. Plasmid DNA sequences present in conventional herpes simplex virus amplicon vectors cause rapid transgene silencing by forming inactive chromatin. J Virol 2006;80(7):3293-300
- Chen ZY, He CY, Ehrhardt A, Kay MA. Minicircle DNA vectors devoid of bacterial DNA result in persistent and high-level transgene expression in vivo. Mol Ther 2003;8(3):495-500
- Federoff HJ, Bowers WJ. Helper virus-free herpesvirus amplicon particles and uses thereof. WO2007143681; 2007
- Hackett PB, Ivics Z, Izsvak Z, Caldovic L. DNA-based transposon system for the introduction of nucleic acid into DNA of cell. WO9840510; 1998
- Hackett PB, Clark KJ, Dupuy AJ, et al. Nucleic acid transfer vector for the introduction of nucleic acid into the DNA of a cell. WO9925817; 1999
- Ivics Z, Hackett PB, Plasterk RH, Izsvak Z. Molecular reconstruction of Sleeping Beauty, a Tc1-like transposon from fish, and its transposition in human cells. Cell 1997;91(4):501-10
- Bowers WJ, Mastrangelo MA, Howard DF, et al. Neuronal precursor-restricted transduction via in utero CNS gene delivery of a novel bipartite HSV amplicon/transposase hybrid vector. Mol Ther 2006;13(3):580-8
- Liu ML, Winther BL, Kay MA. Pseudotransduction of hepatocytes by using concentrated pseudotyped vesicular stomatitis virus G glycoprotein (VSV-G)-Moloney murine leukemia virus-derived retrovirus vectors: comparison of VSV-G and amphotropic vectors for hepatic gene transfer. J Virol 1996;70(4):2497-502
- Alexander IE, Russell DW, Miller AD. Transfer of contaminants in adeno-associated virus vector stocks can mimic transduction and lead to artifactual results. Hum Gene Ther 1997;8(16):1911-20
- Epstein AL, Marconi P, Argnani R, Manservini R. HSV-1-derived recombinant and amplicon vectors for gene transfer and gene therapy. Curr Gene Ther 2005;5:445-58
- Willis RA, Bowers WJ, Turner MJ, et al. Dendritic cells transduced with HSV-1 amplicons expressing prostate-specific antigen generate antitumor immunity in mice. Hum Gene Ther 2001;12(15):1867-79
- Hocknell PK, Wiley RD, Wang X, et al. Expression of human immunodeficiency virus type 1 gp120 from herpes simplex virus type 1-derived amplicons results in potent, specific, and durable cellular and humoral immune responses. J Virol 2002;76(11):5565-80
- Wang X, Wiley RD, Evans TG, et al. Cellular immune responses to helper-free HSV-1 amplicon particles encoding HIV-1 gp120 are enhanced by DNA priming. Vaccine 2003;21(19-20):2288-97
- Gorantla S, Santos K, Meyer V, et al. Human dendritic cells transduced with herpes simplex virus amplicons encoding human immunodeficiency virus type 1 (HIV-1) gp120 elicit adaptive immune responses from human cells engrafted into NOD/SCID mice and confer partial protection against HIV-1 challenge. J Virol 2005;79(4):2124-32
- Tolba KA, Bowers WJ, Eling DJ, et al. HSV amplicon-mediated delivery of LIGHT enhances the antigen-presenting capacity of chronic lymphocytic leukemia. Mol Ther 2002;6(4):455-63
- Tolba KA, Bowers WJ, Hilchey SP, et al. Development of herpes simplex virus-1 amplicon-based immunotherapy for chronic lymphocytic leukemia. Blood 2001;98(2):287-95
- Chen X, Frisina RD, Bowers WJ, et al. HSV amplicon-mediated neurotrophin-3 expression protects murine spiral ganglion neurons from cisplatin-induced damage. Mol Ther 2001;3(6):958-63
- Bowers WJ, Chen X, Guo H, et al. Neurotrophin-3 transduction attenuates cisplatin spiral ganglion neuron ototoxicity in the cochlea. Mol Ther 2002;6(1):12-8
- Frazer ME, Hughes JE, Mastrangelo MA, et al. Reduced pathology and improved behavioral performance in Alzheimer's disease mice vaccinated with HSV amplicons expressing amyloid-beta and interleukin-4. Mol Ther 2008;16(5):845-53
- Federoff HJ, Bowers WJ. Methods of producing Herpes simplex virus amplicons, resulting amplicons and their use. WO200189304; 2001
- Johnston KM, Jacoby D, Pechan PA, et al. HSV/AAV hybrid amplicon vectors extend transgene expression in human glioma cells. Hum Gene Ther 1997;8(3):359-70
- Fraefel C, Jacoby DR, Lage C, et al. Gene transfer into hepatocytes mediated by helper virus-free HSV/AAV hybrid vectors. Mol Med 1997;3(12):813-25
- Lam P, Hui KM, Wang Y, et al. Dynamics of transgene expression in human glioblastoma cells mediated by herpes simplex virus/adeno-associated virus amplicon vectors. Hum Gene Ther 2002;13(18):2147-59
- Wang Y, Camp SM, Niwano M, et al. Herpes simplex virus type 1/adeno-associated virus rep(+) hybrid amplicon vector improves the stability of transgene expression in human cells by site-specific integration. J Virol 2002;76(14):7150-62
- Heister T, Heid I, Ackermann M, Fraefel C. Herpes simplex virus type 1/adeno-associated virus hybrid vectors mediate site-specific integration at the adeno-associated virus preintegration site, AAVS1, on human chromosome 19. J Virol 2002;76(14):7163-73
- Bakowska JC, Di Maria MV, Camp SM, et al. Targeted transgene integration into transgenic mouse fibroblasts carrying the full-length human AAVS1 locus mediated by HSV/AAV rep(+) hybrid amplicon vector. Gene Ther 2003;10(19):1691-702
- Heilbronn R, Burkle A, Stephan S, Zur Hausen H. The adeno-associated virus rep gene suppresses herpes simplex virus-induced DNA amplification. J Virol 1990;64(6):3012-8
- Glauser DL, Saydam O, Balsiger NA, et al. Four-dimensional visualization of the simultaneous activity of alternative adeno-associated virus replication origins. J Virol 2005;79(19):12218-30
- Liu Q, Perez CF, Wang Y. Efficient site-specific integration of large transgenes by an enhanced herpes simplex virus/adeno-associated virus hybrid amplicon vector. J Virol 2006;80(4):1672-9
- Moralli D, Simpson KM, Wade-Martins R, Monaco ZL. A novel human artificial chromosome gene expression system using herpes simplex virus type 1 vectors. EMBO Rep 2006;7(9):911-8